Milagros Altamirano-Molina

ORCID: 0000-0002-1071-212X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and Retrovirus Studies
  • Vector-Borne Animal Diseases
  • Acute Lymphoblastic Leukemia research
  • Neutropenia and Cancer Infections
  • Animal Disease Management and Epidemiology
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Viral-associated cancers and disorders
  • Chronic Lymphocytic Leukemia Research
  • Bacterial Identification and Susceptibility Testing
  • SARS-CoV-2 and COVID-19 Research
  • Autoimmune and Inflammatory Disorders Research
  • COVID-19 Clinical Research Studies
  • Childhood Cancer Survivors' Quality of Life
  • Streptococcal Infections and Treatments
  • SARS-CoV-2 detection and testing

National University of San Marcos
2022-2024

Hospital Base Guillermo Almenara Irigoyen
2019-2023

The University of Texas MD Anderson Cancer Center
2021

Waldenstrom Macroglobulinemia (WM) is a rare lymphoma with distinct clinical features, and data from Latin American patients are lacking. Therefore, we aim to investigate the clinical, therapy, outcome patterns of WM in America.We retrospectively analyzed diagnosed between 1991 2019 24 centers seven countries. The study outcomes were overall survival (OS) progression-free (PFS).We identified 159 cases (median age 67 years, male 62%). Most (95%) symptomatic at diagnosis. International...

10.1200/go.21.00380 article EN cc-by-nc-nd JCO Global Oncology 2022-08-01

PURPOSE Adult T-cell leukemia/lymphoma (ATLL) is an aggressive disease caused by the human leukemia virus type 1. Real-world data of ATLL in Latin America are lacking. PATIENTS AND METHODS We analyzed patients with (acute, lymphomatous, chronic, and smoldering) encountered 11 American countries between 1995 2019. Treatment response was assessed according to 2009 consensus report. Survival curves were estimated using Kaplan-Meier method log-rank test. RESULTS identified 253 patients; 226...

10.1200/go.21.00084 article EN cc-by-nc-nd JCO Global Oncology 2021-07-16

The addition of Biofire® FilmArray® Blood Culture Identification panel 2 (BCID2) to the antimicrobial stewardship program (ASP) could improve outcomes in bloodstream infections (BSI) patients with febrile neutropenia (FN). A pre- and post-quasi-experimental single-center study was conducted at a reference hospital Peru. Three groups were considered: BSI before ASP intervention (control group), after (group 1), plus BCID2 PCR Panel implementation 2). Overall, 93 identified (32 control, 30...

10.3390/antibiotics12040648 article EN cc-by Antibiotics 2023-03-24

isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in seven patients with a diagnosis leukemia and confirmation disease (COVID-19) admitted to the Hematology Depart-

10.1016/j.htct.2021.11.017 article EN cc-by-nc-nd Hematology Transfusion and Cell Therapy 2022-01-19

Background: Acute lymphoblastic leukemia (ALL) is the most common neoplasm in pediatric and adolescent populations. Overall survival has improved recent decades. This study aimed to assess overall of patients with ALL a Latin American hospital. Materials Methods: A longitudinal retrospective analytical was conducted on 31 less than 16 years age diagnosed at hematology department Peruvian hospital during period 2015-2016. 5 determined using Kaplan-Meier curve parametric log-rank tests, Cox...

10.18502/ijpho.v14i3.15985 article EN Iranian Journal of Pediatric Hematology & Oncology 2024-06-30

Adult T-cell leukemia/lymphoma (ATLL) is a lymphoid neoplasm caused by the human lymphotropic virus type 1 (HTLV-1), an endemic retrovirus in our country. It has heterogeneous presentation, with sub types of poor prognosis, and opportunistic infections that worsen prognosis. We present two cases aggressive varieties disease (acute lymphomatous) complicated systemic cryptococcosis. necessary to conduct complete diagnostic approach continuous monitoring agents patients ATL adapted...

10.24265/horizmed.2019.v19n1.14 article EN cc-by Horizonte Médico (Lima) 2019-03-15

Se presenta el caso de un paciente varón seis años edad, con síndrome hemofagocítico secundario a infección por virus Epstein-Barr. El inició cuadro fiebre,hepatoesplenomegalia, falla hepática, trastornos la coagulación, ferritina, triglicéridos y disminución todas las líneas celulares hematológicas. aspirado médula ósea evidenció presencia citofagocitosis, lo que tratamiento específico según protocolo HLH 2004, respondiendo favorablemente luego cuatro semanas. Actualmente, continúa sus...

10.35663/amp.2019.363.837 article ES cc-by ACTA MEDICA PERUANA 2019-12-06
Coming Soon ...